Acquired factor V deficiency is a rare bleeding disorder that develops later in life, often after surgery, exposure to certain antibiotics, or contact with bovine thrombin in surgical glues. People with acquired factor V deficiency may have easy bruising, nosebleeds, gum bleeding, heavy menstrual bleeding, blood in urine or stool, or prolonged bleeding after minor cuts or procedures. Many people first hear about acquired factor V deficiency when unexpected bleeding does not stop as usual after dental work or an operation. It can affect adults of any age, and symptoms can range from mild to severe depending on how low factor V levels are and whether inhibitors are present. Treatment focuses on stopping bleeding with platelet transfusions and plasma, and on reducing antibodies with steroids or other medicines, and most people improve once the underlying trigger is treated.
Overview
Acquired factor v deficiencySymptoms
Acquired factor V deficiency causes unusual bleeding and bruising. This can mean frequent nosebleeds, bleeding gums, heavy periods, or prolonged bleeding after cuts, dental work, or surgery; some notice blood in urine or stool.
Outlook and prognosis
Many people with acquired factor V deficiency do well once the trigger is found and treated, such as an antibody from an infection, medication exposure, or after surgery. Bleeding risk often improves with targeted therapy and careful monitoring. Relapses can happen, so ongoing follow-up with your care team matters.
Causes and risk factors
Acquired factor V deficiency often stems from immune inhibitors triggered by bovine thrombin during surgery, antibiotics, infections, transfusions, cancers, or autoimmune disease. Risk increases after procedures, pregnancy, or inflammation. Genetics seldom contributes; lifestyle factors have minimal impact.
Genetic influences
Genetics play little to no role in acquired factor V deficiency. It usually develops from immune reactions, certain exposures, or other conditions rather than inherited variants. Rarely, underlying genetic tendencies to autoimmunity may modestly influence risk, but inheritance isn’t the driver.
Diagnosis
Doctors diagnose acquired factor V deficiency with blood clotting tests, measuring factor V activity, and a mixing test to check for an antibody (inhibitor). They also review medicines and history, and rule out inherited factor V deficiency.
Treatment and drugs
Treatment for acquired factor V deficiency focuses on stopping bleeding and restoring factor V levels. Care may include platelet transfusions, fresh frozen plasma, or prothrombin complex, along with medicines like steroids, IVIG, or rituximab to calm inhibitors. Doctors also treat any trigger, such as infection, surgery, or an underlying autoimmune condition.
Symptoms
Bleeding that’s hard to stop, bruises that seem to appear out of nowhere, or long oozing after dental work can disrupt everyday plans. In acquired factor V deficiency, the blood doesn’t clot as efficiently, so bleeding can be more frequent or last longer than expected. Early symptoms of acquired factor V deficiency are often mild—things like easy bruising or nosebleeds—but more serious bleeding can happen, especially after surgery or an injury. Symptoms vary from person to person and can change over time.
Bruises from minor bumps show up more often or in larger patches. Early on, this might look like marks that appear after light pressure or routine activity. They may take longer than usual to fade.
Bleeding from the nose can start suddenly and be hard to stop. Episodes may last longer than 10 minutes or return during the same day. Dry air or a cold can set them off more easily.
Gums may bleed with brushing or flossing. Dental cleanings can lead to oozing that lasts hours. Using a soft brush may help but often doesn’t fully prevent it.
Menstrual bleeding can be heavier, last more than 7 days, or include large clots. This can cause tiredness or dizziness from low iron. People with acquired factor V deficiency may need medical support to manage flow.
How people usually first notice Acquired factor v deficiency?
People usually first notice acquired factor V deficiency when unexpected bleeding shows up after an injury, dental work, or surgery—bruises that spread, nosebleeds that are hard to stop, or bleeding gums. Some also see prolonged menstrual bleeding or notice that small cuts take a long time to clot, and a doctor may flag an unusually long clotting time on routine blood tests. These early clues often lead to testing that confirms low factor V activity and helps identify the trigger, such as an autoimmune inhibitor, certain antibiotics, or a severe liver problem.
Types of Acquired factor v deficiency
Acquired factor V deficiency can show up in a few recognizable ways, depending on whether bleeding, clotting, or lab-test changes stand out first. People may notice different sets of symptoms depending on their situation. Some experience nosebleeds or easy bruising, while others learn about it only after a blood test or a surgery with unexpected bleeding. Here are the main types to know about:
Bleeding‑predominant
Easy bruising, nosebleeds, gum bleeding, or heavier periods are common. Some have prolonged bleeding after dental work, injections, or surgery. Severe cases may involve internal bleeding with weakness or shortness of breath.
Clotting‑predominant
Less common, but some develop blood clots in the legs or lungs. This can happen when inhibitors interfere with factor V in a way that tilts the balance toward clotting. Symptoms can include leg swelling or sudden chest pain and breathlessness.
Laboratory‑first
Abnormal clotting tests are found before symptoms, often during pre‑op checks or workups for bruising. Mixing studies and factor assays point to acquired factor V deficiency. Not everyone will experience every type.
Transfusion‑related
Symptoms start after exposure to certain blood products or bovine‑derived thrombin used in surgery. People may notice unexpected bleeding soon after a procedure. Loved ones may recognize certain types sooner than the person experiencing them.
Autoimmune‑associated
Linked with conditions like autoimmune disease, infections, cancer, or certain medicines that trigger inhibitors. Bleeding ranges from mild to severe depending on inhibitor levels. The balance of symptoms can shift over time.
Post‑surgical onset
Bleeding appears in the days to weeks after an operation, sometimes at the incision or drain sites. Clinicians often describe them in these categories: bleeding‑predominant, clotting‑predominant, and laboratory‑first. If you notice one or more of these symptom types, bring it up at your next appointment.
What genetics can tell you about symptoms
Certain HLA types (like DRB1*08) can trigger antibodies that block factor V, leading to sudden bruising, nosebleeds, heavy periods, or bleeding after procedures. People with autoimmune conditions, infections, or exposure to topical bovine thrombin may notice worse or prolonged bleeding.
Causes and risk factors
Acquired factor V deficiency usually happens when the immune system makes antibodies that block the clotting protein factor V. Known risk factors for acquired factor V deficiency include surgery that uses surgical clotting products or a blood transfusion. It is also linked to some antibiotics or other medicines, infections, cancer, pregnancy, and autoimmune disease. It is not usually driven by inherited genes, so family history has little effect. Doctors distinguish between risk factors you can change and those you can’t, and lifestyle factors play little role.
Environmental and biological risk factors
Acquired factor V deficiency can surface after certain medical exposures or health conditions, sometimes showing up as unexpected bleeding during recovery. Doctors often group risks into internal (biological) and external (environmental). Below are environmental and biological risk factors for acquired factor V deficiency that clinicians watch for.
Exposure to bovine thrombin or similar proteins used to control bleeding in the operating room can trigger antibodies against factor V. This immune reaction can lead to acquired factor V deficiency days to weeks after surgery.
Operations can expose the blood to materials and inflammation that affect clotting balance. These changes can contribute to inhibitor formation or consumption of factor V.
Some drugs, particularly certain antibiotics, have been associated with developing an inhibitor to factor V. This is uncommon, but clinicians may check for it when bleeding begins after a new medication.
Immune system activity that mistakenly targets the body's own proteins can spill over to factor V. People with autoimmune disease have a higher chance of developing inhibitors that cause acquired factor V deficiency.
Genetic risk factors
Genetics play little to no role in acquired factor V deficiency, which typically develops for non-inherited reasons. Family members usually are not at higher risk, and routine DNA testing does not help confirm this diagnosis. Risk is not destiny—it varies widely between individuals.
No genetic cause: In most people, acquired factor V deficiency does not result from inherited gene changes. The condition develops without a heritable mutation.
Inherited form separate: The inherited form of factor V deficiency is a different, rare bleeding disorder present from birth. It does not explain an acquired diagnosis later in life.
Family history minimal: A family history of bleeding usually does not raise genetic risk for acquired factor V deficiency. Most cases occur with no family pattern.
HLA markers unproven: Research has not confirmed consistent HLA types or other genetic markers that increase risk. Any inherited predisposition remains unproven at this time.
Genetic testing limited: Routine genetic testing is not helpful for diagnosing acquired factor V deficiency. Testing is mainly considered to rule out the inherited form when needed.
Ancestry not specific: No ancestry or population group has a confirmed genetic risk for acquired factor V deficiency. Reported cases span diverse backgrounds.
Symptoms not genetic: Genetic traits do not determine early symptoms of acquired factor V deficiency. What you notice usually reflects the current factor V level rather than family genes.
Lifestyle risk factors
Acquired factor V deficiency is influenced less by genetics and more by habits that affect liver health and bleeding risk. Key lifestyle risk factors for acquired factor V deficiency include alcohol use, metabolic health, medication and supplement choices, and activity intensity. While lifestyle can’t cause all cases, it can worsen bleeding or reduce factor V production by straining the liver. Thoughtful adjustments may lower bleeding complications and support safer daily living.
Heavy or chronic drinking injures the liver, which can reduce factor V production and raise bleeding risk. Cutting back or stopping alcohol helps preserve clotting factor synthesis.
Obesity and insulin resistance can lead to fatty liver disease, which may impair factor V production as liver inflammation or fibrosis progresses. Weight management and a balanced diet support healthy hepatic clotting factor output.
Frequent use of NSAIDs or aspirin impairs platelet function and can magnify bleeding when factor V is low. Discuss safer pain options to minimize additive bleeding risk.
Supplements like ginkgo, garlic, fish oil, and high‑dose vitamin E can heighten bleeding tendency in factor V deficiency. Always review supplements with a clinician to adjust doses or stop risky products.
Risk prevention
For a rare condition like acquired factor V deficiency, prevention focuses on avoiding known triggers and catching issues early. Work with your care team to plan around surgeries, medicines, and other exposures that can spark bleeding problems. Keeping liver health on track and treating underlying conditions lowers the chance of complications. Knowing your risks can guide which preventive steps matter most.
Before any operation or dental procedure, tell the team you are concerned about acquired factor V deficiency. Ask them to avoid products that can trigger antibodies, such as bovine thrombin sealants, and to consider alternatives.
Review new prescriptions and over-the-counter drugs with your clinician, especially antibiotics. Avoid unnecessary antibiotics and report unusual bruising or bleeding soon after starting a new medicine.
Keep your liver healthy by limiting alcohol, staying up to date on hepatitis A and B vaccines, and managing fatty liver risk through nutrition and activity. Better liver function supports steadier clotting factor production, which may lower bleeding risk.
If you live with an autoimmune condition, regular follow-up and good disease control can reduce immune flare-ups that may contribute to acquired factor V deficiency. Work with your specialist to adjust treatment when needed.
Transmission
Acquired factor V deficiency is not contagious and cannot be passed from one person to another. It does not spread through casual contact, sex, saliva, or shared items, and there’s no genetic transmission of acquired factor V deficiency—families are not at increased risk. This condition develops inside the body when the immune system interferes with factor V, sometimes after medical exposures or other health events, but it is not an infection. Because it isn’t transmissible, there are no isolation or contact precautions for people living with acquired factor V deficiency.
When to test your genes
Consider genetic testing if you’ve had unexplained or recurrent blood clots, a strong family history of thrombosis at a young age, or clots in unusual sites (like cerebral or abdominal veins). Testing also helps tailor care before high‑risk moments—pregnancy, major surgery, estrogen therapy, or long flights. Discuss timing with your clinician to align results with treatment decisions.
Diagnosis
Acquired factor V deficiency is usually picked up when unexpected or easy bleeding leads to blood tests, then confirmed with more focused clotting studies. The diagnosis of acquired factor V deficiency often unfolds step by step, starting with your story and basic labs and moving to specific factor testing. Many people find reassurance in knowing what their tests can—and can’t—show. From here, the focus shifts to confirming or ruling out possible causes.
Your clinician asks about bruising, nosebleeds, gum bleeding, heavy periods, or bleeding after surgery or dental work. They also review past procedures, infections, and autoimmune symptoms.
Doctors look for recent antibiotics, herbal supplements, or other medicines that might affect clotting. Prior exposure to surgical sealants or glues is noted because certain products have been linked to acquired factor V deficiency.
Initial labs usually include prothrombin time (PT/INR) and activated partial thromboplastin time (aPTT). In acquired factor V deficiency, both can be prolonged while the thrombin time is typically normal.
Your plasma is mixed with normal plasma to see if clotting times correct. Lack of correction suggests an inhibitor to factor V rather than a simple shortage.
Stages of Acquired factor v deficiency
Acquired factor V deficiency does not have defined progression stages. It tends to appear unpredictably and can change over time, often depending on the level of an inhibitor in the blood, and it’s identified mainly through clotting tests rather than a steady, stepwise decline. If you’re noticing early symptoms of acquired factor V deficiency like easy bruising, nosebleeds, or bleeding that’s harder to stop after a dental visit, doctors usually start with simple clotting tests and a measurement of factor V levels. Different tests may be suggested to help confirm the cause and guide treatment, including follow-up studies that look for an antibody interfering with factor V.
Outlook and prognosis
Daily routines often adapt when bleeding is unpredictable—someone might skip a workout after noticing easy bruising or plan ahead for dental work because gums bleed longer than expected with acquired factor V deficiency. The outlook is not the same for everyone, but small mucosal bleeds are more common than life‑threatening events. Serious complications like internal bleeding or bleeding inside the skull are rare, yet they can occur, especially if the deficiency is severe or goes unrecognized during surgery or childbirth.
Understanding the prognosis can guide planning and day‑to‑day choices. In many cases, treating the trigger—such as stopping an offending medication, addressing an underlying autoimmune issue, or managing a related cancer or infection—leads to improvement over weeks to months. Some people experience long stretches with minimal symptoms, while others notice bleeding returns if the underlying cause flares again. Early care can make a real difference, particularly when care teams have a plan for procedures and know the early symptoms of acquired factor V deficiency to watch for.
Mortality is generally low when the condition is identified promptly and managed in a hospital setting with supportive measures. Treatment may include transfusions, targeted therapies to calm the immune response, and careful planning before any surgery or dental work; with ongoing care, many people maintain an active life and avoid major bleeds. Talk with your doctor about what your personal outlook might look like, especially if you have other health conditions or need an operation in the near future.
Long-term effects
For many, acquired factor V deficiency can lead to a tendency to bleed that lasts months to years, depending on the cause and whether the inhibitor fades. Early symptoms of acquired factor V deficiency may include easy bruising, nosebleeds, or bleeding after dental work, and these can continue if the underlying trigger persists. Long-term effects vary widely, from minimal issues to repeated bleeds that affect energy and day-to-day plans. With treatment of the trigger, many people with acquired factor V deficiency recover fully, but some have relapses and need ongoing follow-up.
Easy bruising, nose or gum bleeding, and prolonged bleeding from small cuts can continue over time. For some, minor bumps or dental work lead to noticeable bleeds.
Ongoing blood loss can lead to iron‑deficiency anemia and tiredness. People may notice shortness of breath with stairs or less stamina during everyday tasks.
Periods can be heavier or longer than usual and may recur month after month. For some, this contributes to anemia and fatigue.
Surgeries, biopsies, or dental work can bring on excessive bleeding during or after the procedure. Doctors may track these changes over years to see how stable bleeding risk is.
How is it to live with Acquired factor v deficiency?
Living with acquired factor V deficiency can feel unpredictable, because easy bruising, nosebleeds, or prolonged bleeding after minor cuts or dental work may pop up when you least expect them. Many people learn to plan ahead—carrying pressure bandages, checking medications that raise bleeding risk (like aspirin or certain antibiotics), and coordinating closely before surgeries or even routine procedures. Day to day, most activities are doable with a few precautions, but loved ones and coworkers may need a quick primer on what to do if bleeding starts and why extra time or medical checks are sometimes necessary. With a clear care plan from your clinician, regular follow-up, and smart prevention, many find a steady rhythm that keeps life active and safe.
Treatment and drugs
Treatment for acquired factor V deficiency focuses on stopping bleeding, replacing missing factor V temporarily, and addressing the underlying cause. In emergencies, doctors may use platelet transfusions, fresh frozen plasma, or a pooled product called prothrombin complex concentrate to boost clotting while they work to control active bleeding or prepare for surgery. If the deficiency is caused by antibodies (inhibitors), treatment often includes corticosteroids, intravenous immune globulin (IVIG), or other immune-suppressing medicines to lower or remove those antibodies; in severe cases, therapies like plasmapheresis or rituximab may be used. Alongside medical treatment, lifestyle choices play a role, such as avoiding unnecessary blood thinners and planning procedures with your care team, since early symptoms of acquired factor V deficiency can include easy bruising or prolonged bleeding after minor cuts. Ask your doctor about the best starting point for you, especially if your deficiency developed after an infection, surgery, antibiotic exposure, or a topical bovine thrombin product, because removing the trigger can help recovery.
Non-drug treatment
Living with acquired factor V deficiency often means planning ahead to prevent and control bleeding in everyday life. Non-drug treatments often lay the foundation for care, whether you are having dental work or a planned surgery. These approaches focus on removing triggers, supporting clotting with blood products, and using local measures to stop bleeding. Your team will tailor options based on how much bleeding you have and whether an inhibitor is present.
Identify and stop likely triggers, such as exposure to bovine thrombin during surgery or a recently started antibiotic. Your clinicians may adjust procedures or products to avoid re-exposure in the future. This step can reduce ongoing bleeding in acquired factor V deficiency.
Platelets carry factor V and can help control bleeding, especially when an inhibitor is present. They are often used for active bleeding or just before a procedure. Doses and timing are tailored to your situation.
This provides factor V and can offer short-term support during bleeding episodes or procedures. It may be less effective if a strong inhibitor is circulating in acquired factor V deficiency. Close lab checks help decide how much and how often to give it.
Plasma exchange (plasmapheresis) can temporarily remove the inhibitor from the bloodstream. It is sometimes used to prepare for urgent surgery or to manage severe bleeding. Teams often pair it with transfusion support.
Your genes may have an impact on how drugs work for you
Your genes can affect how your body processes treatments for acquired factor V deficiency, including how you activate or clear clotting factors and respond to immunosuppressive medicines. Because of this, doctors may adjust drug type or dose and monitor labs closely.
Pharmacological treatments
Treatment focuses on stopping bleeding and quieting the immune reaction that blocks factor V. There isn’t a readily available factor V concentrate, so doctors use a mix of medicines to control bleeding and lower the antibody that’s causing the problem. Options can be combined or stepped through depending on severity and response. Not everyone responds to the same medication in the same way.
Prednisone is often started to dial down the immune system and reduce the inhibitor. Some cases add cyclophosphamide if steroids alone aren’t enough. This combination aims to clear the inhibitor over weeks.
This targeted antibody therapy can lower the B‑cells that make the anti–factor V antibody. It’s used when steroids aren’t effective or to speed inhibitor clearance. Treatment is typically given by infusion over several weeks.
Intravenous immunoglobulin can modulate the immune response and help neutralize the inhibitor temporarily. It’s often used alongside steroids or rituximab in more stubborn cases.
Platelets carry usable factor V inside them, so transfusions can help control active bleeding. Doctors may repeat doses, especially around surgery or procedures.
Genetic influences
Acquired factor V deficiency is usually not driven by genes, because it develops when the immune system makes a protein that blocks factor V rather than from a change you’re born with. It’s natural to ask whether family history plays a role. For most people with acquired factor V deficiency, there’s no family pattern; it often appears after a trigger in adult life, so relatives are typically unaffected. This is different from the rare inherited form of factor V deficiency, which runs in families and tends to show up in childhood. Because the acquired type is not typically hereditary, genetic testing isn’t routinely needed; it may be considered only if bleeding started early in life or several relatives have similar symptoms. If you’re wondering whether acquired factor V deficiency is inherited, the short answer is no—though your care team may still ask about family history to rule out inherited bleeding disorders. Also, the well-known factor V Leiden trait is a separate genetic issue that increases clotting risk and is not a cause of acquired factor V deficiency.
Is Acquired factor v deficiency genetic?
Genetics play little to no role in acquired factor V deficiency. It usually develops from immune reactions, certain exposures, or other conditions rather than inherited variants. Rarely, underlying genetic tendencies to autoimmunity may modestly influence risk, but inheritance isn’t the driver.
Pharmacogenetics—how genetics influence drug effects
Because this condition is acquired rather than inherited, your genes usually don’t cause the bleeding problem itself. However, genetics can still shape how you respond to some of the medicines used to quiet the immune system and remove the inhibitor behind acquired factor V deficiency. Your genetic makeup can affect how fast your body processes certain immune‑suppressing drugs, like azathioprine; people with specific enzyme differences (often checked with a TPMT or NUDT15 test) may need lower doses to avoid serious side effects such as very low white blood cells. If these medicines are part of the treatment of acquired factor V deficiency, your care team may consider this testing or look for prior results in your record. For other treatments — steroids, cyclophosphamide, rituximab, antifibrinolytics like tranexamic acid, or special clotting medicines sometimes called “bypassing agents” — routine genetic testing isn’t standard, though any known inherited bleeding or clotting tendencies can influence dosing and monitoring. Genetics is only one factor, and doctors also weigh your bleeding severity, triggers (for example, recent surgery or certain antibiotics), and other health conditions. When discussing drugs used to treat acquired factor V deficiency, ask whether any existing genetic results could guide safer dosing or reduce side effects.
Interactions with other conditions
Acquired factor v deficiency often shows up alongside another health issue or after an exposure, rather than on its own. To understand overall health, it’s useful to see how conditions overlap. Autoimmune diseases (like lupus), certain cancers, infections, some antibiotics, and prior surgery using certain clotting products made from animal proteins can trigger antibodies that block factor V and raise bleeding risk. Liver disease or a widespread clotting problem in the bloodstream can further lower clotting factors and platelets, so bleeding from acquired factor V deficiency may be worse during those times. Blood thinners and antiplatelet medicines used for heart or stroke prevention can also intensify bleeding and make dosing decisions more complex. If another illness flares, early symptoms of Acquired factor v deficiency—such as easy bruising, nosebleeds, or gum bleeding—may resurface, so let your care team know if you notice changes.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of unusual bruising or bleeding after surgery or childbirth, long before lab tests could point to a cause. Some people bled heavily only when exposed to certain products or medications in the hospital, while everyday cuts at home were mild. These stories hinted that something in the blood’s clotting system could be interfered with, but the trigger wasn’t obvious.
From early theories to modern research, the story of acquired factor V deficiency has moved from scattered case reports to a clearer picture. In the mid-20th century, doctors began documenting people who suddenly developed bleeding after contact with topical fibrin sealants used in surgery—many of which were made with bovine (cow) proteins. Soon, similar episodes appeared after certain antibiotics or with autoimmune conditions, where the body mistakenly made antibodies that blocked factor V, a key clotting protein. Reports also surfaced after exposure to particular antiseptics or blood products, helping clinicians connect the dots between triggers and sudden changes in clotting.
Initially understood only through symptoms, later cases were confirmed with lab patterns that showed prolonged clotting times and low factor V activity, yet normal levels of other clotting factors. Mixing studies—combining a person’s plasma with normal plasma—helped reveal that an antibody was inhibiting factor V rather than the body simply not making enough of it. This shifted thinking from a rare curiosity to a recognized, if uncommon, acquired bleeding disorder with identifiable causes.
With each decade, clinicians refined how they describe acquired factor V deficiency and how they manage it. Early on, stopping the suspected trigger and giving plasma were the mainstays. As understanding grew, treatments aimed at the underlying immune response—such as corticosteroids or other immunosuppressive medicines—were used when antibodies were the driver. Surgeons and anesthesiologists became more alert to avoid bovine-derived products in people with a history of reactions, and hospitals reviewed perioperative materials to reduce risk.
Understandings have changed, but one theme has stayed constant: acquired factor V deficiency can appear suddenly in people with no prior bleeding history. This has pushed teams to ask about recent surgeries, new medications, disinfectants, and transfusions when unexplained bleeding occurs. Today, case registries and shared protocols help specialists recognize patterns sooner, tailor treatment, and follow recovery over weeks to months. The condition remains uncommon, yet its history shows how careful observation, paired with targeted testing, has improved safety during procedures and helped many return to everyday life with confidence.